Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will advance a range of conjugates, unlimited by indication, using their own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.

Biotechnology

Tubulis

Dominik Schumacher

Adriane Krahe

Matthew Norkunas

Bettina Deisenrieder

John Smither

Yariv Houvras

Eckart Frehe

Andreas Montag

Julia Stiegeler

Ines Vasconcelos

Jonas Helma-Smets

Mary Ann Lumiqued

Günter Fingerle-Rowson

Armin Weidmann

Ingo Lehrke

Heinrich Leonhardt

Philipp Ochtrop

Christian Hackenberger

Pamela Trail

Debasish Roychowdhury

Valentin Piëch

Sofia Ioannidou

Christian Grøndahl

Björn Hock

Christoph Broja

Caroline Goddeeris

Kanishka Pothula

Description

People (13)

Dominik Schumacher

Jonas Helma-Smets

Annette Vogl

Philipp Ochtrop

Olivier Marcq

Mary Ann Lumiqued

Annabel Kitowski

Elizaveta Poliak

Jan Felber

Natascia Leonardi

Katharina Heinzelmann

Manuela Duerr

Svea B.

Jobs